GB202405997D0 - Novel compositions - Google Patents
Novel compositionsInfo
- Publication number
- GB202405997D0 GB202405997D0 GBGB2405997.4A GB202405997A GB202405997D0 GB 202405997 D0 GB202405997 D0 GB 202405997D0 GB 202405997 A GB202405997 A GB 202405997A GB 202405997 D0 GB202405997 D0 GB 202405997D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- novel compositions
- compositions
- novel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2405997.4A GB202405997D0 (en) | 2024-04-29 | 2024-04-29 | Novel compositions |
| PCT/EP2025/061742 WO2025229006A1 (en) | 2024-04-29 | 2025-04-29 | Compositions comprising dalbavancin |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2405997.4A GB202405997D0 (en) | 2024-04-29 | 2024-04-29 | Novel compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB202405997D0 true GB202405997D0 (en) | 2024-06-12 |
Family
ID=91375464
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB2405997.4A Ceased GB202405997D0 (en) | 2024-04-29 | 2024-04-29 | Novel compositions |
Country Status (2)
| Country | Link |
|---|---|
| GB (1) | GB202405997D0 (en) |
| WO (1) | WO2025229006A1 (en) |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7119061B2 (en) | 2002-11-18 | 2006-10-10 | Vicuron Pharmaceuticals, Inc. | Dalbavancin compositions for treatment of bacterial infections |
| RU2675859C2 (en) | 2012-11-29 | 2018-12-25 | Инсмед Инкорпорейтед | Stabilised vancomycin formulations |
| HRP20200101T1 (en) | 2014-11-06 | 2020-04-03 | Xellia Pharmaceuticals Aps | Glycopeptide compositions |
| MX2018001571A (en) | 2015-08-05 | 2018-09-06 | Childrens Medical Center | Compositions with permeation enhancers for drug delivery. |
| WO2017179003A1 (en) * | 2016-04-15 | 2017-10-19 | Lupin Limited | Topical compositions for ophthalmic and otic use |
| RU2019119405A (en) | 2016-11-23 | 2020-12-25 | Гуфик Байосайенсиз Лимитед | DALBAVANCIN LYOPHILIZED PHARMACEUTICAL COMPOSITIONS |
| CA3132923A1 (en) | 2019-03-08 | 2020-09-17 | Emphascience, Inc. | Stable pharmaceutical formulations of peptide and protein drugs |
| US12343373B2 (en) | 2020-10-30 | 2025-07-01 | Somerset Therapeutics, Llc | Glycopeptide antibiotics liquid formulations and methods and uses thereof |
| WO2024079223A1 (en) * | 2022-10-12 | 2024-04-18 | Xellia Pharmaceuticals Aps | Liquid dalbavancin composition |
| EP4601616A1 (en) * | 2022-10-12 | 2025-08-20 | Hikma Pharmaceuticals USA Inc. | Liquid dalbavancin composition |
-
2024
- 2024-04-29 GB GBGB2405997.4A patent/GB202405997D0/en not_active Ceased
-
2025
- 2025-04-29 WO PCT/EP2025/061742 patent/WO2025229006A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2025229006A1 (en) | 2025-11-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB202415499D0 (en) | Novel compositions | |
| GB202405997D0 (en) | Novel compositions | |
| GB202405996D0 (en) | Novel compositions | |
| GB202511471D0 (en) | Exosome-based compositions | |
| GB202510664D0 (en) | Compositions | |
| GB202505602D0 (en) | Compositions | |
| GB202500743D0 (en) | Compositions | |
| GB202411739D0 (en) | Compositions | |
| GB202407447D0 (en) | Aquafeed compositions | |
| GB202404395D0 (en) | Compositions | |
| GB202501526D0 (en) | Improved compositions | |
| GB202507755D0 (en) | New compositions | |
| GB202504553D0 (en) | Novel composition | |
| GB202504551D0 (en) | Novel composition | |
| GB202504550D0 (en) | Novel composition | |
| GB202415475D0 (en) | Novel composition | |
| GB202415070D0 (en) | Novel composition | |
| GB202402906D0 (en) | Novel composition | |
| GB202316194D0 (en) | Novel compositions | |
| GB202217025D0 (en) | Novel compositions | |
| GB202510711D0 (en) | Composition | |
| GB202509639D0 (en) | Composition | |
| GB202508491D0 (en) | Composition | |
| GB202508302D0 (en) | Transcytosing composition | |
| GB202507920D0 (en) | Composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| COOA | Change in applicant's name or ownership of the application |
Owner name: HELM PHARMACEUTICALS GMBH Free format text: FORMER OWNER: ARECOR LIMITED |
|
| AT | Applications terminated before publication under section 16(1) |